RHEUMATOID PLEURITIS

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting RHEUMATOID PLEURITIS:

# Drug Count
0 ETELCALCETIDE 2
1 ANTACID 1
2 CALCIUM CARBONATE 1
3 ERYTHROPOIETIN 1
4 INFLIXIMAB 1
5 INTERFERON BETA-1A 1
6 NIRMATRELVIR AND RITONAVIR 1
7 TOCILIZUMAB 1
See all common drugs associated with RHEUMATOID PLEURITIS

RHEUMATOID PLEURITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETELCALCETIDE 2 0.0007
1 ERYTHROPOIETIN 1 0.0000
2 NIRMATRELVIR AND RITONAVIR 1 0.0000
3 CALCIUM CARBONATE 1 0.0000
4 TOCILIZUMAB 1 0.0000
5 INTERFERON BETA-1A 1 0.0000
6 INFLIXIMAB 1 0.0000
See all drugs enriched for association with RHEUMATOID PLEURITIS

These drug classes are most commonly taken by patients reporting RHEUMATOID PLEURITIS:

# Drug class Count
0 Interferon beta [EPC] 1
1 Interleukin-6 Receptor Antagonist [EPC] 1
2 Tumor Necrosis Factor Blocker [EPC] 1
See all common drug classes associated with RHEUMATOID PLEURITIS

RHEUMATOID PLEURITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
1 Interferon beta [EPC] 1 0.0000
2 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
See all drug classes enriched for association with RHEUMATOID PLEURITIS